{"id":9666,"date":"2023-10-31T09:59:13","date_gmt":"2023-10-31T08:59:13","guid":{"rendered":"https:\/\/diario.m-achermann.com\/qui-jetais-et-qui-je-suis\/leucemie-myeloide-chronique-lmc-quest-ce-que-cest\/"},"modified":"2026-04-01T16:49:39","modified_gmt":"2026-04-01T14:49:39","slug":"leucemie-myeloide-chronique-lmc-quest-ce-que-cest","status":"publish","type":"page","link":"https:\/\/diario.m-achermann.com\/fr\/qui-jetais-et-qui-je-suis\/leucemie-myeloide-chronique-lmc-quest-ce-que-cest\/","title":{"rendered":"Leuc\u00e9mie my\u00e9lo\u00efde chronique (LMC), qu\u2019est-ce que c\u2019est ?"},"content":{"rendered":"\n<p class=\"has-medium-font-size\">   <\/p>\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full\"><img decoding=\"async\" width=\"520\" height=\"392\" src=\"https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2023\/10\/Hypolobated_small_megakaryocyte-2.jpg\" alt=\"\" class=\"wp-image-621\" srcset=\"https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2023\/10\/Hypolobated_small_megakaryocyte-2.jpg 520w, https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2023\/10\/Hypolobated_small_megakaryocyte-2-300x226.jpg 300w\" sizes=\"(max-width: 520px) 100vw, 520px\" \/><figcaption class=\"wp-element-caption\">Cela ressemble \u00e0 une belle peinture abstraite, et pourtant : un petit <a href=\"https:\/\/it.wikipedia.org\/wiki\/Megacariocita\">m\u00e9gacaryocyte<\/a> au noyau hypolob\u00e9 dans un aspirat de moelle osseuse d\u2019un patient atteint de leuc\u00e9mie my\u00e9lo\u00efde chronique<\/figcaption><\/figure>\n<\/div>\n<p>  <\/p>\n\n<p class=\"has-medium-font-size\"><strong>La maladie<\/strong><\/p>\n\n<p>La <strong>leuc\u00e9mie my\u00e9lo\u00efde chronique<\/strong> (<strong>LMC<\/strong>) est une condition clinique pathologique d\u00e9termin\u00e9e par la prolif\u00e9ration <a href=\"https:\/\/it.wikipedia.org\/wiki\/Clone_(biologia_cellulare)\">monoclonale<\/a> incontr\u00f4l\u00e9e d\u2019une seule cellule multipotente ayant subi une transformation n\u00e9oplasique. <br\/>La maladie peut impliquer les lign\u00e9es my\u00e9lo\u00efde, monocytaire, \u00e9rythro\u00efde, m\u00e9gacaryocytaire et parfois aussi le compartiment lympho\u00efde.<br\/><strong>Les ann\u00e9es 2005-2010 ont vu un changement radical dans la th\u00e9rapie et le pronostic de la leuc\u00e9mie my\u00e9lo\u00efde chronique, gr\u00e2ce \u00e0 l\u2019utilisation des connaissances sur la pathogen\u00e8se mol\u00e9culaire de la maladie ; cette am\u00e9lioration a \u00e9t\u00e9 compar\u00e9e \u00e0 la d\u00e9couverte des antibiotiques pour le traitement des maladies bact\u00e9riennes.<br\/><\/strong>Il existe de nombreux traitements possibles pour la leuc\u00e9mie my\u00e9lo\u00efde chronique, mais le standard pour les nouveaux diagnostics est la th\u00e9rapie par <a href=\"https:\/\/it.wikipedia.org\/wiki\/Imatinib\">Imatinib<\/a>. <br\/>Par rapport \u00e0 la plupart des m\u00e9dicaments anticanc\u00e9reux, l\u2019imatinib poss\u00e8de relativement peu d\u2019effets secondaires et peut \u00eatre pris par voie orale \u00e0 domicile. Avec ce m\u00e9dicament, plus de 90 % des patients parviennent \u00e0 maintenir la maladie sous contr\u00f4le pendant au moins cinq ans, rendant cette condition chronique g\u00e9rable. <br\/><em>Source : <a href=\"https:\/\/it.wikipedia.org\/wiki\/Leucemia_mieloide_cronica\">https:\/\/it.wikipedia.org\/wiki\/Leucemia_mieloide_cronica<\/a><\/em><\/p>\n\n<p class=\"has-medium-font-size\"><strong>\u00c9pid\u00e9miologie<\/strong><\/p>\n\n<p>L\u2019incidence dans les pays industrialis\u00e9s est de 2 cas pour 100\u202f000 personnes par an ; en ce qui concerne le sexe, les hommes sont les plus touch\u00e9s (rapport H:F = 2:1). <br\/>Elle frappe \u00e0 tout \u00e2ge, 20 \u00e0 25 % des cas ayant plus de 60 ans. <br\/>L\u2019\u00e2ge m\u00e9dian au diagnostic est de 45-50 ans ; en Italie, on compte environ 800 \u00e0 1 000 nouveaux cas chaque ann\u00e9e et le nombre total de patients est d\u2019environ 10\u202f000, en constante augmentation.<br\/><em>Source : <a href=\"https:\/\/it.wikipedia.org\/wiki\/Leucemia_mieloide_cronica\">https:\/\/it.wikipedia.org\/wiki\/Leucemia_mieloide_cronica<\/a><\/em><\/p>\n\n<p class=\"has-medium-font-size\"><strong>Leuc\u00e9mie my\u00e9lo\u00efde chronique en Suisse 2000-2007, d\u2019apr\u00e8s<\/strong> <strong><a href=\"https:\/\/www.nicer.org\/assets\/files\/publications\/others\/1179-1500.pdf\">Les cancers en Suisse, rapport 2015 <\/a><\/strong> <\/p>\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"475\" src=\"https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2023\/10\/SopravvivenzaSvizzera2016-1024x475.jpg\" alt=\"\" class=\"wp-image-526\" srcset=\"https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2023\/10\/SopravvivenzaSvizzera2016-1024x475.jpg 1024w, https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2023\/10\/SopravvivenzaSvizzera2016-300x139.jpg 300w, https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2023\/10\/SopravvivenzaSvizzera2016-768x356.jpg 768w, https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2023\/10\/SopravvivenzaSvizzera2016-1536x712.jpg 1536w, https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2023\/10\/SopravvivenzaSvizzera2016-2048x949.jpg 2048w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"447\" src=\"https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2023\/10\/LMC_eta-1024x447.jpg\" alt=\"\" class=\"wp-image-527\" srcset=\"https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2023\/10\/LMC_eta-1024x447.jpg 1024w, https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2023\/10\/LMC_eta-300x131.jpg 300w, https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2023\/10\/LMC_eta-768x336.jpg 768w, https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2023\/10\/LMC_eta-1536x671.jpg 1536w, https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2023\/10\/LMC_eta-2048x895.jpg 2048w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"418\" src=\"https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2023\/10\/LMC_1-5-10-1024x418.jpg\" alt=\"\" class=\"wp-image-528\" srcset=\"https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2023\/10\/LMC_1-5-10-1024x418.jpg 1024w, https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2023\/10\/LMC_1-5-10-300x122.jpg 300w, https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2023\/10\/LMC_1-5-10-768x313.jpg 768w, https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2023\/10\/LMC_1-5-10-1536x626.jpg 1536w, https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2023\/10\/LMC_1-5-10-2048x835.jpg 2048w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"469\" src=\"https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2023\/10\/LMC_5-1024x469.jpg\" alt=\"\" class=\"wp-image-529\" srcset=\"https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2023\/10\/LMC_5-1024x469.jpg 1024w, https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2023\/10\/LMC_5-300x137.jpg 300w, https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2023\/10\/LMC_5-768x352.jpg 768w, https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2023\/10\/LMC_5-1536x703.jpg 1536w, https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2023\/10\/LMC_5-2048x938.jpg 2048w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2023\/10\/LMC_Epidio.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Contenu embarqu\u00e9 LMC_Epidio.\"><\/object><a id=\"wp-block-file--media-e111d106-1011-474f-86a5-23c3c5486d8b\" href=\"https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2023\/10\/LMC_Epidio.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">LMC_Epidio<\/a><a href=\"https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2023\/10\/LMC_Epidio.pdf\" class=\"wp-block-file__button wp-element-button\" download=\"\" aria-describedby=\"wp-block-file--media-e111d106-1011-474f-86a5-23c3c5486d8b\">T\u00e9l\u00e9charger<\/a><\/div>\n\n<p>Internet regorge d\u2019informations \u00e0 ce sujet, mais je ne souhaite pas vous lasser davantage avec des informations techniques et scientifiques.<br\/>Revenons au r\u00e9cit et aux souvenirs de cette p\u00e9riode.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La maladie La leuc\u00e9mie my\u00e9lo\u00efde chronique (LMC) est une condition clinique pathologique d\u00e9termin\u00e9e par la prolif\u00e9ration monoclonale incontr\u00f4l\u00e9e d\u2019une seule cellule multipotente ayant subi une transformation n\u00e9oplasique. La maladie peut impliquer les lign\u00e9es my\u00e9lo\u00efde, monocytaire, \u00e9rythro\u00efde, m\u00e9gacaryocytaire et parfois aussi le compartiment lympho\u00efde.Les ann\u00e9es 2005-2010 ont vu un changement radical dans la th\u00e9rapie et le&hellip;&nbsp;<a href=\"https:\/\/diario.m-achermann.com\/fr\/qui-jetais-et-qui-je-suis\/leucemie-myeloide-chronique-lmc-quest-ce-que-cest\/\" rel=\"bookmark\">Read More &raquo;<span class=\"screen-reader-text\">Leuc\u00e9mie my\u00e9lo\u00efde chronique (LMC), qu\u2019est-ce que c\u2019est ?<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":9486,"menu_order":40,"comment_status":"open","ping_status":"closed","template":"","meta":{"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","om_disable_all_campaigns":false,"_lmt_disableupdate":"","_lmt_disable":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","neve_meta_reading_time":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[],"tags":[],"class_list":["post-9666","page","type-page","status-publish","hentry"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO Pro 4.9.7.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"D\u00e9couvrez ce qu\u2019est la leuc\u00e9mie my\u00e9lo\u00efde chronique, une pathologie caract\u00e9ris\u00e9e par une prolif\u00e9ration cellulaire incontr\u00f4l\u00e9e, ainsi que les r\u00e9cents progr\u00e8s th\u00e9rapeutiques, tels que l\u2019Imatinib.\" \/>\n\t<meta name=\"robots\" content=\"max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n\t<meta name=\"google-site-verification\" content=\"2kcNb_eND2p_5dJ-aEUjUzdL5U1pyWvu9G-2F4Qyiwk\" \/>\n\t<meta name=\"msvalidate.01\" content=\"8A32EFC1288A3ACC21FB6846BFC9E656\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/diario.m-achermann.com\/fr\/qui-jetais-et-qui-je-suis\/leucemie-myeloide-chronique-lmc-quest-ce-que-cest\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO Pro (AIOSEO) 4.9.7.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"fr_FR\" \/>\n\t\t<meta property=\"og:site_name\" content=\"ECMO - Journal d&#039;une vie boulevers\u00e9e - Mon aventure, ou plut\u00f4t ma m\u00e9saventure ? De la chance ou de la malchance ?\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Leuc\u00e9mie my\u00e9lo\u00efde chronique : causes, traitements et perspectives\" \/>\n\t\t<meta property=\"og:description\" content=\"D\u00e9couvrez ce qu\u2019est la leuc\u00e9mie my\u00e9lo\u00efde chronique, une pathologie caract\u00e9ris\u00e9e par une prolif\u00e9ration cellulaire incontr\u00f4l\u00e9e, ainsi que les r\u00e9cents progr\u00e8s th\u00e9rapeutiques, tels que l\u2019Imatinib.\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/diario.m-achermann.com\/fr\/qui-jetais-et-qui-je-suis\/leucemie-myeloide-chronique-lmc-quest-ce-que-cest\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2024\/02\/Mirko.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2024\/02\/Mirko.png\" \/>\n\t\t<meta property=\"og:image:width\" content=\"200\" \/>\n\t\t<meta property=\"og:image:height\" content=\"200\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2023-10-31T08:59:13+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-04-01T14:49:39+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61556963490212\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:site\" content=\"@Mapi1967\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Leuc\u00e9mie my\u00e9lo\u00efde chronique : causes, traitements et perspectives\" \/>\n\t\t<meta name=\"twitter:description\" content=\"D\u00e9couvrez ce qu\u2019est la leuc\u00e9mie my\u00e9lo\u00efde chronique, une pathologie caract\u00e9ris\u00e9e par une prolif\u00e9ration cellulaire incontr\u00f4l\u00e9e, ainsi que les r\u00e9cents progr\u00e8s th\u00e9rapeutiques, tels que l\u2019Imatinib.\" \/>\n\t\t<meta name=\"twitter:creator\" content=\"@Mapi1967\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2024\/02\/Mirko.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/diario.m-achermann.com\\\/fr\\\/qui-jetais-et-qui-je-suis\\\/leucemie-myeloide-chronique-lmc-quest-ce-que-cest\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/diario.m-achermann.com\\\/fr\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/diario.m-achermann.com\\\/fr\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/diario.m-achermann.com\\\/fr\\\/qui-jetais-et-qui-je-suis\\\/#listItem\",\"name\":\"Qui j\\u2019\\u00e9tais et qui je suis\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/diario.m-achermann.com\\\/fr\\\/qui-jetais-et-qui-je-suis\\\/#listItem\",\"position\":2,\"name\":\"Qui j\\u2019\\u00e9tais et qui je suis\",\"item\":\"https:\\\/\\\/diario.m-achermann.com\\\/fr\\\/qui-jetais-et-qui-je-suis\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/diario.m-achermann.com\\\/fr\\\/qui-jetais-et-qui-je-suis\\\/leucemie-myeloide-chronique-lmc-quest-ce-que-cest\\\/#listItem\",\"name\":\"Leuc\\u00e9mie my\\u00e9lo\\u00efde chronique (LMC), qu\\u2019est-ce que c\\u2019est ?\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/diario.m-achermann.com\\\/fr\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/diario.m-achermann.com\\\/fr\\\/qui-jetais-et-qui-je-suis\\\/leucemie-myeloide-chronique-lmc-quest-ce-que-cest\\\/#listItem\",\"position\":3,\"name\":\"Leuc\\u00e9mie my\\u00e9lo\\u00efde chronique (LMC), qu\\u2019est-ce que c\\u2019est ?\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/diario.m-achermann.com\\\/fr\\\/qui-jetais-et-qui-je-suis\\\/#listItem\",\"name\":\"Qui j\\u2019\\u00e9tais et qui je suis\"}}]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/diario.m-achermann.com\\\/fr\\\/#person\",\"name\":\"Mirko Achermann\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/diario.m-achermann.com\\\/fr\\\/qui-jetais-et-qui-je-suis\\\/leucemie-myeloide-chronique-lmc-quest-ce-que-cest\\\/#personImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/53bb9dac79236bd713fbe107c9f2410ca8a6094577846073d4bea7d0bab1e51f?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"Mirko Achermann\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/diario.m-achermann.com\\\/fr\\\/qui-jetais-et-qui-je-suis\\\/leucemie-myeloide-chronique-lmc-quest-ce-que-cest\\\/#webpage\",\"url\":\"https:\\\/\\\/diario.m-achermann.com\\\/fr\\\/qui-jetais-et-qui-je-suis\\\/leucemie-myeloide-chronique-lmc-quest-ce-que-cest\\\/\",\"name\":\"Leuc\\u00e9mie my\\u00e9lo\\u00efde chronique : causes, traitements et perspectives\",\"description\":\"D\\u00e9couvrez ce qu\\u2019est la leuc\\u00e9mie my\\u00e9lo\\u00efde chronique, une pathologie caract\\u00e9ris\\u00e9e par une prolif\\u00e9ration cellulaire incontr\\u00f4l\\u00e9e, ainsi que les r\\u00e9cents progr\\u00e8s th\\u00e9rapeutiques, tels que l\\u2019Imatinib.\",\"inLanguage\":\"fr-FR\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/diario.m-achermann.com\\\/fr\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/diario.m-achermann.com\\\/fr\\\/qui-jetais-et-qui-je-suis\\\/leucemie-myeloide-chronique-lmc-quest-ce-que-cest\\\/#breadcrumblist\"},\"datePublished\":\"2023-10-31T09:59:13+01:00\",\"dateModified\":\"2026-04-01T16:49:39+02:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/diario.m-achermann.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/diario.m-achermann.com\\\/fr\\\/\",\"name\":\"ECMO \\u2013 Diario di una vita stravolta\",\"alternateName\":\"ECMO\",\"description\":\"Mon aventure, ou plut\\u00f4t ma m\\u00e9saventure ? De la chance ou de la malchance ?\",\"inLanguage\":\"fr-FR\",\"publisher\":{\"@id\":\"https:\\\/\\\/diario.m-achermann.com\\\/fr\\\/#person\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO Pro -->\r\n\t\t<title>Leuc\u00e9mie my\u00e9lo\u00efde chronique : causes, traitements et perspectives<\/title>\n\n","aioseo_head_json":{"title":"Leuc\u00e9mie my\u00e9lo\u00efde chronique : causes, traitements et perspectives","description":"D\u00e9couvrez ce qu\u2019est la leuc\u00e9mie my\u00e9lo\u00efde chronique, une pathologie caract\u00e9ris\u00e9e par une prolif\u00e9ration cellulaire incontr\u00f4l\u00e9e, ainsi que les r\u00e9cents progr\u00e8s th\u00e9rapeutiques, tels que l\u2019Imatinib.","canonical_url":"https:\/\/diario.m-achermann.com\/fr\/qui-jetais-et-qui-je-suis\/leucemie-myeloide-chronique-lmc-quest-ce-que-cest\/","robots":"max-snippet:-1, max-image-preview:large, max-video-preview:-1","keywords":"","webmasterTools":{"google-site-verification":"2kcNb_eND2p_5dJ-aEUjUzdL5U1pyWvu9G-2F4Qyiwk","msvalidate.01":"8A32EFC1288A3ACC21FB6846BFC9E656","miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/diario.m-achermann.com\/fr\/qui-jetais-et-qui-je-suis\/leucemie-myeloide-chronique-lmc-quest-ce-que-cest\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/diario.m-achermann.com\/fr\/#listItem","position":1,"name":"Home","item":"https:\/\/diario.m-achermann.com\/fr\/","nextItem":{"@type":"ListItem","@id":"https:\/\/diario.m-achermann.com\/fr\/qui-jetais-et-qui-je-suis\/#listItem","name":"Qui j\u2019\u00e9tais et qui je suis"}},{"@type":"ListItem","@id":"https:\/\/diario.m-achermann.com\/fr\/qui-jetais-et-qui-je-suis\/#listItem","position":2,"name":"Qui j\u2019\u00e9tais et qui je suis","item":"https:\/\/diario.m-achermann.com\/fr\/qui-jetais-et-qui-je-suis\/","nextItem":{"@type":"ListItem","@id":"https:\/\/diario.m-achermann.com\/fr\/qui-jetais-et-qui-je-suis\/leucemie-myeloide-chronique-lmc-quest-ce-que-cest\/#listItem","name":"Leuc\u00e9mie my\u00e9lo\u00efde chronique (LMC), qu\u2019est-ce que c\u2019est ?"},"previousItem":{"@type":"ListItem","@id":"https:\/\/diario.m-achermann.com\/fr\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/diario.m-achermann.com\/fr\/qui-jetais-et-qui-je-suis\/leucemie-myeloide-chronique-lmc-quest-ce-que-cest\/#listItem","position":3,"name":"Leuc\u00e9mie my\u00e9lo\u00efde chronique (LMC), qu\u2019est-ce que c\u2019est ?","previousItem":{"@type":"ListItem","@id":"https:\/\/diario.m-achermann.com\/fr\/qui-jetais-et-qui-je-suis\/#listItem","name":"Qui j\u2019\u00e9tais et qui je suis"}}]},{"@type":"Person","@id":"https:\/\/diario.m-achermann.com\/fr\/#person","name":"Mirko Achermann","image":{"@type":"ImageObject","@id":"https:\/\/diario.m-achermann.com\/fr\/qui-jetais-et-qui-je-suis\/leucemie-myeloide-chronique-lmc-quest-ce-que-cest\/#personImage","url":"https:\/\/secure.gravatar.com\/avatar\/53bb9dac79236bd713fbe107c9f2410ca8a6094577846073d4bea7d0bab1e51f?s=96&d=mm&r=g","width":96,"height":96,"caption":"Mirko Achermann"}},{"@type":"WebPage","@id":"https:\/\/diario.m-achermann.com\/fr\/qui-jetais-et-qui-je-suis\/leucemie-myeloide-chronique-lmc-quest-ce-que-cest\/#webpage","url":"https:\/\/diario.m-achermann.com\/fr\/qui-jetais-et-qui-je-suis\/leucemie-myeloide-chronique-lmc-quest-ce-que-cest\/","name":"Leuc\u00e9mie my\u00e9lo\u00efde chronique : causes, traitements et perspectives","description":"D\u00e9couvrez ce qu\u2019est la leuc\u00e9mie my\u00e9lo\u00efde chronique, une pathologie caract\u00e9ris\u00e9e par une prolif\u00e9ration cellulaire incontr\u00f4l\u00e9e, ainsi que les r\u00e9cents progr\u00e8s th\u00e9rapeutiques, tels que l\u2019Imatinib.","inLanguage":"fr-FR","isPartOf":{"@id":"https:\/\/diario.m-achermann.com\/fr\/#website"},"breadcrumb":{"@id":"https:\/\/diario.m-achermann.com\/fr\/qui-jetais-et-qui-je-suis\/leucemie-myeloide-chronique-lmc-quest-ce-que-cest\/#breadcrumblist"},"datePublished":"2023-10-31T09:59:13+01:00","dateModified":"2026-04-01T16:49:39+02:00"},{"@type":"WebSite","@id":"https:\/\/diario.m-achermann.com\/fr\/#website","url":"https:\/\/diario.m-achermann.com\/fr\/","name":"ECMO \u2013 Diario di una vita stravolta","alternateName":"ECMO","description":"Mon aventure, ou plut\u00f4t ma m\u00e9saventure ? De la chance ou de la malchance ?","inLanguage":"fr-FR","publisher":{"@id":"https:\/\/diario.m-achermann.com\/fr\/#person"}}]},"og:locale":"fr_FR","og:site_name":"ECMO - Journal d'une vie boulevers\u00e9e - Mon aventure, ou plut\u00f4t ma m\u00e9saventure ? De la chance ou de la malchance ?","og:type":"article","og:title":"Leuc\u00e9mie my\u00e9lo\u00efde chronique : causes, traitements et perspectives","og:description":"D\u00e9couvrez ce qu\u2019est la leuc\u00e9mie my\u00e9lo\u00efde chronique, une pathologie caract\u00e9ris\u00e9e par une prolif\u00e9ration cellulaire incontr\u00f4l\u00e9e, ainsi que les r\u00e9cents progr\u00e8s th\u00e9rapeutiques, tels que l\u2019Imatinib.","og:url":"https:\/\/diario.m-achermann.com\/fr\/qui-jetais-et-qui-je-suis\/leucemie-myeloide-chronique-lmc-quest-ce-que-cest\/","og:image":"https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2024\/02\/Mirko.png","og:image:secure_url":"https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2024\/02\/Mirko.png","og:image:width":200,"og:image:height":200,"article:published_time":"2023-10-31T08:59:13+00:00","article:modified_time":"2026-04-01T14:49:39+00:00","article:publisher":"https:\/\/www.facebook.com\/profile.php?id=61556963490212","twitter:card":"summary_large_image","twitter:site":"@Mapi1967","twitter:title":"Leuc\u00e9mie my\u00e9lo\u00efde chronique : causes, traitements et perspectives","twitter:description":"D\u00e9couvrez ce qu\u2019est la leuc\u00e9mie my\u00e9lo\u00efde chronique, une pathologie caract\u00e9ris\u00e9e par une prolif\u00e9ration cellulaire incontr\u00f4l\u00e9e, ainsi que les r\u00e9cents progr\u00e8s th\u00e9rapeutiques, tels que l\u2019Imatinib.","twitter:creator":"@Mapi1967","twitter:image":"https:\/\/diario.m-achermann.com\/wp-content\/uploads\/2024\/02\/Mirko.png"},"aioseo_meta_data":{"post_id":"9666","title":"Leuc\u00e9mie my\u00e9lo\u00efde chronique : causes, traitements et perspectives","description":"D\u00e9couvrez ce qu\u2019est la leuc\u00e9mie my\u00e9lo\u00efde chronique, une pathologie caract\u00e9ris\u00e9e par une prolif\u00e9ration cellulaire incontr\u00f4l\u00e9e, ainsi que les r\u00e9cents progr\u00e8s th\u00e9rapeutiques, tels que l\u2019Imatinib.","keywords":null,"keyphrases":{"focus":{"keyphrase":"Leucemia","score":80,"analysis":{"keyphraseInTitle":{"score":9,"maxScore":9,"error":0},"keyphraseInDescription":{"score":9,"maxScore":9,"error":0},"keyphraseLength":{"score":9,"maxScore":9,"error":0,"length":1},"keyphraseInURL":{"score":5,"maxScore":5,"error":0},"keyphraseInIntroduction":{"score":3,"maxScore":9,"error":1},"keyphraseInSubHeadings":[],"keyphraseInImageAlt":{"score":3,"maxScore":9,"error":1},"keywordDensity":{"type":"best","score":9,"maxScore":9,"error":0}}},"additional":[{"keyphrase":"LMC","score":60,"analysis":{"keyphraseInDescription":{"score":3,"maxScore":9,"error":1},"keyphraseLength":{"score":9,"maxScore":9,"error":0,"length":1},"keyphraseInIntroduction":{"score":3,"maxScore":9,"error":1},"keyphraseInImageAlt":{"score":3,"maxScore":9,"error":1},"keywordDensity":{"type":"best","score":9,"maxScore":9,"error":0}}},{"keyphrase":"Mieloide","score":53,"analysis":{"keyphraseInDescription":{"score":9,"maxScore":9,"error":0},"keyphraseLength":{"score":9,"maxScore":9,"error":0,"length":1},"keyphraseInIntroduction":{"score":3,"maxScore":9,"error":1},"keyphraseInImageAlt":{"score":3,"maxScore":9,"error":1},"keywordDensity":{"type":"high","score":0,"maxScore":9,"error":1}}},{"keyphrase":"Cronica","score":53,"analysis":{"keyphraseInDescription":{"score":9,"maxScore":9,"error":0},"keyphraseLength":{"score":9,"maxScore":9,"error":0,"length":1},"keyphraseInIntroduction":{"score":3,"maxScore":9,"error":1},"keyphraseInImageAlt":{"score":3,"maxScore":9,"error":1},"keywordDensity":{"type":"high","score":0,"maxScore":9,"error":1}}},{"keyphrase":"studi","score":40,"analysis":{"keyphraseInDescription":{"score":3,"maxScore":9,"error":1},"keyphraseLength":{"score":9,"maxScore":9,"error":0,"length":1},"keyphraseInIntroduction":{"score":3,"maxScore":9,"error":1},"keyphraseInImageAlt":{"score":3,"maxScore":9,"error":1},"keywordDensity":{"score":0,"type":"low","maxScore":9,"error":1}}},{"keyphrase":"ricerca","score":40,"analysis":{"keyphraseInDescription":{"score":3,"maxScore":9,"error":1},"keyphraseLength":{"score":9,"maxScore":9,"error":0,"length":1},"keyphraseInIntroduction":{"score":3,"maxScore":9,"error":1},"keyphraseInImageAlt":{"score":3,"maxScore":9,"error":1},"keywordDensity":{"score":0,"type":"low","maxScore":9,"error":1}}},{"keyphrase":"speranza","score":40,"analysis":{"keyphraseInDescription":{"score":3,"maxScore":9,"error":1},"keyphraseLength":{"score":9,"maxScore":9,"error":0,"length":1},"keyphraseInIntroduction":{"score":3,"maxScore":9,"error":1},"keyphraseInImageAlt":{"score":3,"maxScore":9,"error":1},"keywordDensity":{"score":0,"type":"low","maxScore":9,"error":1}}},{"keyphrase":"speranza di vita","score":40,"analysis":{"keyphraseInDescription":{"score":3,"maxScore":9,"error":1},"keyphraseLength":{"score":9,"maxScore":9,"error":0,"length":3},"keyphraseInIntroduction":{"score":3,"maxScore":9,"error":1},"keyphraseInImageAlt":{"score":3,"maxScore":9,"error":1},"keywordDensity":{"score":0,"type":"low","maxScore":9,"error":1}}},{"keyphrase":"vita","score":40,"analysis":{"keyphraseInDescription":{"score":3,"maxScore":9,"error":1},"keyphraseLength":{"score":9,"maxScore":9,"error":0,"length":1},"keyphraseInIntroduction":{"score":3,"maxScore":9,"error":1},"keyphraseInImageAlt":{"score":3,"maxScore":9,"error":1},"keywordDensity":{"score":0,"type":"low","maxScore":9,"error":1}}}]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"WebPage","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"seo_analyzer_scan_date":"2026-04-01 15:47:52","breadcrumb_settings":null,"limit_modified_date":0,"reviewed_by":null,"open_ai":"{\"title\":{\"suggestions\":[],\"usage\":0},\"description\":{\"suggestions\":[],\"usage\":0}}","ai":{"faqs":[],"keyPoints":[],"titles":["Leucemia mieloide cronica: cause, trattamenti e prospettive","Scopri la leucemia mieloide cronica: sintomi, diagnosi e terapie efficaci","Leucemia mieloide cronica: come immunoterapia e Imatinib rivoluzionano la cura","Tutto sulla leucemia mieloide cronica: epidemiologia e nuovi approcci terapeutici","Guida comprensiva alla leucemia mieloide cronica: fattori di rischio e avanzamenti scientifici"],"descriptions":["Scopri cos'\u00e8 la leucemia mieloide cronica, una condizione caratterizzata da una proliferazione cellulare incontrollata e i recenti progressi nella terapia, come l'Imatinib.","La leucemia mieloide cronica coinvolge molte linee di cellule midollari e, grazie ai nuovi trattamenti, ora pu\u00f2 essere gestita come una condizione cronica in molti casi.","Esplora le cause, la diagnosi e le innovazioni terapeutiche della leucemia mieloide cronica, una patologia che colpisce prevalentemente adulti sopra i 45 anni.","Approfondisci come la leucemia mieloide cronica venga trattata oggi, con terapie come l'Imatinib, migliorando significativamente la prognosi dei pazienti.","Conoscere la leucemia mieloide cronica \u00e8 fondamentale: dall'incidenza epidemiologica alle moderne strategie terapeutiche, questa malattia sta evolvendo grazie alla ricerca."],"socialPosts":{"email":[],"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"created":"2026-04-01 14:49:36","updated":"2026-04-01 17:42:11"},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/diario.m-achermann.com\/fr\/\" title=\"Home\">Home<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/diario.m-achermann.com\/fr\/qui-jetais-et-qui-je-suis\/\" title=\"Qui j\u2019\u00e9tais et qui je suis\">Qui j\u2019\u00e9tais et qui je suis<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\tLeuc\u00e9mie my\u00e9lo\u00efde chronique (LMC), qu\u2019est-ce que c\u2019est ?\n<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/diario.m-achermann.com\/fr\/"},{"label":"Qui j\u2019\u00e9tais et qui je suis","link":"https:\/\/diario.m-achermann.com\/fr\/qui-jetais-et-qui-je-suis\/"},{"label":"Leuc\u00e9mie my\u00e9lo\u00efde chronique (LMC), qu\u2019est-ce que c\u2019est ?","link":"https:\/\/diario.m-achermann.com\/fr\/qui-jetais-et-qui-je-suis\/leucemie-myeloide-chronique-lmc-quest-ce-que-cest\/"}],"_links":{"self":[{"href":"https:\/\/diario.m-achermann.com\/fr\/wp-json\/wp\/v2\/pages\/9666","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/diario.m-achermann.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/diario.m-achermann.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/diario.m-achermann.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/diario.m-achermann.com\/fr\/wp-json\/wp\/v2\/comments?post=9666"}],"version-history":[{"count":1,"href":"https:\/\/diario.m-achermann.com\/fr\/wp-json\/wp\/v2\/pages\/9666\/revisions"}],"predecessor-version":[{"id":9667,"href":"https:\/\/diario.m-achermann.com\/fr\/wp-json\/wp\/v2\/pages\/9666\/revisions\/9667"}],"up":[{"embeddable":true,"href":"https:\/\/diario.m-achermann.com\/fr\/wp-json\/wp\/v2\/pages\/9486"}],"wp:attachment":[{"href":"https:\/\/diario.m-achermann.com\/fr\/wp-json\/wp\/v2\/media?parent=9666"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/diario.m-achermann.com\/fr\/wp-json\/wp\/v2\/categories?post=9666"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/diario.m-achermann.com\/fr\/wp-json\/wp\/v2\/tags?post=9666"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}